VST:CC - HealthTech Firm Starts Trading on TSX Venture

Founded in April, 2018, this company strives to fill the ever evolving void between patients, healthcare professionals and service advisors, and bridge the gap between the corporate practice of medicine, legal compliance and customer convenience. And now this company has received final approval to begin trading on the TSX Venture, beginning December 1, 2022.

%VictorySquareTechnologies () () announced that its portfolio company, %HydreightTechnologies () has received final approval for its qualifying transaction as principally described in its filing statement dated November 10, 2022, from the TSX Venture Exchange and its common shares have commenced trading on the TSXV under the symbol 'NURS' effective at market open on December 1, 2022, per the company’s press release.

VST CEO Shafin Diamond Tejani said, “I am delighted for Shane and the entire team at Hydreight, this is an opportune time for Hydreight to continue its exponential growth and also provide value to VST and our shareholders as our latest incubated company to publicly list on the TSX-V.”

Shares of Victory Square were trading at $0.145, while new shares of Hydreight were trading at $0.65.